Literature DB >> 25664811

New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Yanju Bao1, Yebo Gao, Liping Yang, Xiangying Kong, Honggang Zheng, Wei Hou, Baojin Hua.   

Abstract

Pain is an unpleasant sensory and emotional experience that is commonly associated with actual or potential tissue damage. Despite decades of pain research, many patients continue to suffer from chronic pain that is refractory to current treatments. Accumulating evidence has indicated an important role of protease-activated receptor 4 (PAR4) in the pathogenesis of inflammation and neuropathic pain. Here we reviewed PAR4 expression and activation via intracellular signaling pathways and the role of PAR4 signaling pathways in the development and maintenance of pain. Understanding PAR4 and its corresponding signaling pathways will provide insight to further explore the molecular basis of pain, which will also help to identify new targets for pharmacological intervention for pain relief.

Entities:  

Keywords:  inflammation pain; neuropathic pain; protease-activated receptor 4

Mesh:

Substances:

Year:  2015        PMID: 25664811      PMCID: PMC4594588          DOI: 10.4161/19336950.2014.995001

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  120 in total

Review 1.  Clinical relevance of proteinase activated receptors (pars) in the gut.

Authors:  N Vergnolle
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 2.  Proteases and protease-activated receptors (PARs): novel signals for pain.

Authors:  N Cenac; N Vergnolle
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

Review 3.  Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Authors:  S R Coughlin
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

4.  Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets.

Authors:  Swaminathan Murugappan; Haripriya Shankar; Surya Bhamidipati; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

5.  Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation.

Authors:  Julie Keeble; Fiona Russell; Bradley Curtis; Anna Starr; Erika Pinter; Susan D Brain
Journal:  Arthritis Rheum       Date:  2005-10

Review 6.  The ERK/MAPK pathway, as a target for the treatment of neuropathic pain.

Authors:  Weiya Ma; Remi Quirion
Journal:  Expert Opin Ther Targets       Date:  2005-08       Impact factor: 6.902

7.  Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia.

Authors:  Wan-Jun Zhu; Hiroki Yamanaka; Koichi Obata; Yi Dai; Kimiko Kobayashi; Toyoko Kozai; Atsushi Tokunaga; Koichi Noguchi
Journal:  Brain Res       Date:  2005-04-18       Impact factor: 3.252

8.  Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor.

Authors:  S Tamura; Y Morikawa; E Senba
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

9.  Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase.

Authors:  Durga Prasanna Mohapatra; Carla Nau
Journal:  J Biol Chem       Date:  2005-02-03       Impact factor: 5.157

10.  Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents.

Authors:  Steeve Houle; Martin D Papez; Mara Ferazzini; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

View more
  2 in total

Review 1.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

2.  Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain.

Authors:  Shaojing Ye; Fei Ma; Dlovan F D Mahmood; Katherine L Meyer-Siegler; Raymond E Menard; David E Hunt; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  PLoS One       Date:  2021-08-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.